lorazepam

Generic: lorazepam

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lorazepam
Generic Name lorazepam
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lorazepam 2 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-629
Product ID 64980-629_b47aeb6e-aa7a-469b-a709-15df0e99ea79
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218597
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2025-07-24

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980629
Hyphenated Format 64980-629

Supplemental Identifiers

RxCUI
197900 197901 197902
UNII
O26FZP769L
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lorazepam (source: ndc)
Generic Name lorazepam (source: ndc)
Application Number ANDA218597 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (64980-629-01)
  • 1000 TABLET in 1 BOTTLE (64980-629-10)
  • 500 TABLET in 1 BOTTLE (64980-629-50)
source: ndc

Packages (3)

Ingredients (1)

lorazepam (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b47aeb6e-aa7a-469b-a709-15df0e99ea79", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["O26FZP769L"], "rxcui": ["197900", "197901", "197902"], "spl_set_id": ["386255e2-65aa-48ce-9eb1-246f1493cc14"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (64980-629-01)", "package_ndc": "64980-629-01", "marketing_start_date": "20250724"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (64980-629-10)", "package_ndc": "64980-629-10", "marketing_start_date": "20250724"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (64980-629-50)", "package_ndc": "64980-629-50", "marketing_start_date": "20250724"}], "brand_name": "Lorazepam", "product_id": "64980-629_b47aeb6e-aa7a-469b-a709-15df0e99ea79", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "64980-629", "dea_schedule": "CIV", "generic_name": "Lorazepam", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lorazepam", "active_ingredients": [{"name": "LORAZEPAM", "strength": "2 mg/1"}], "application_number": "ANDA218597", "marketing_category": "ANDA", "marketing_start_date": "20250724", "listing_expiration_date": "20261231"}